Bleichroeder LP Adverum Biotechnologies, Inc. Transaction History

Bleichroeder LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 10, 2021	SELL	$9.84 - $14.26 $1.48 Million - $2.14 Million	-150,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.3 - $21.64 $1.55 Million - $3.25 Million	150,000 New	150,000 $1.55 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.